Testing effectiveness (Phase 2)Study completedNCT00002265
What this trial is testing
An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492
Who this might be right for
HIV Infections
Hoffmann-La Roche